Overall rank by patents
#27,044
of 49,997 tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 6 technology areas, recorded in grant years 2023–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: E21B (Earth OR Rock DRILLING; Obtaining OIL, GAS, Water, Soluble OR Meltable Materials OR A Slurry OF Minerals From Wells).
The verdict
According to USPTO PatentsView, Opla ranks #27,044 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 6 technology areas.
USPTO PatentsView assignee plate
Corpus R27044 · Foreign Corporation #27,044 · 10 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
Nearest grant-volume peer: OncoArendi Therapeutics S.A. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Opla Energy · this assignee
49 score
3D Lighting… · lowest
7 score
What this shows Opla's Innovation Score is 48.8/100 (top 16% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Opla Energy Ltd. is a focused PatentsView assignee: 6 CPC subclasses with 70% of grants classified under E21B (Earth OR Rock DRILLING; Obtaining OIL, GAS, Water, Soluble OR Meltable Materials OR A Slurry OF Minerals From Wells). Peak complete grant year is 2024 (5 grants) versus a trough of 2 in 2023. By volume, Opla sits between OncoArendi Therapeutics S.A. and Oxford BioMedica (UK) Limited.
Opla Energy Ltd. shows 7 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
OncoArendi Therapeutics S.A.
10 patents
One Home Brands, Inc.
10 patents
One Lambda, Inc.
10 patents
One Star International Co., Ltd.
10 patents
Optibiotix Limited
10 patents
Orlandi, Inc.
10 patents
Out of Sight Vision Systems LLC
10 patents
Oxford BioMedica (UK) Limited
10 patents
Opla Energy Ltd.
10 patents
What this shows Opla holds 10 patents at rank #27,050, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #27,050 in granted patent volume.
Other assignees with the most granted patents in Opla's primary technology class.
Opla's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
49 Top 16% higher than 84% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2023 | 2 | 20.0% |
| 2024 | 5 | 50.0% |
| 2025partial year | 3 | 30.0% |
Top 6 of 6 technology areas
Overall rank by patents
#27,044
of 49,997 tracked assignees
48.8 out of 100
What to do with this data
Opla Energy Ltd.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.